Search form

Latest news

Probe Scientific signs a non-exclusive licence with Menarini Diagnostics

19 April 2013

Probe Scientific signs major development and non-exclusive licence agreements with A. Menarini Diagnostics. This will allow Menarini to combine Probe’s MicroEye® blood sampling device with their GlucoMenDay® device for continuous glucose monitoring

BVT Technologies

24 October 2012

Probe Scientific is working closely with BVT technologies to further develop continuous glucose monitoring systems.

NanoDem

24 October 2012

Probe Scientific to take part in European study monitoring immunosuppressants. The €5.2m FP7 funded project features researchers and commercial companies from 6 European counties.

Probe Scientific appoints a new Chairman

1 October 2012

Probe scientific is pleased to announce the appointment of George Zajicek as Chairman. George brings with him significant diagnostic and phmaceutical industry experience.

Probe Scientific announces completion of funding round

8 September 2011

The Board confirmed that it closed an investment round from existing shareholders and directors. This allows Probe to develop new partnerships and applications and allows it to conclude existing licence deals in a range of territories/markets

Exciting commercial and clinical interest in continuous Glucose monitoring at SCCM San Diego Jan 11

28 January 2011

Probe held meetings with a number of commercial companies who are interested in using Probe’s technology. Discussions ranged from those interested in specific applications or analytes to those interested in fully integrated multi analyte applications

Probe opens new office

3 November 2009

Probe's office in the West Midlands is now open.

Key opinion leaders studies confirm previous market data

30 January 2009

Probe has recently completed third party key opinion leader studies in Europe and the USA.

Probe Scientific launches revolutionary MicroEye® system

9 November 2007

Probe Scientific has formally launched MicroEye®, a revolutionary device to solve clinical problems and enhance healthcare through more efficient and effective blood sampling.